July 2, 2021
Better Choice Announces Closing of $40M Underwritten Public Offering
NEW YORK, July 01, 2021 (GLOBE NEWSWIRE) — Better Choice Company (NYSE American: BTTR) (“Better Choice” or the “Company”), an…
Pharmaceuticals, Biotechnology and Life Sciences
NEW YORK, July 01, 2021 (GLOBE NEWSWIRE) — Better Choice Company (NYSE American: BTTR) (“Better Choice” or the “Company”), an…
RESEARCH TRIANGLE PARK, N.C., July 01, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced multiple upcoming data…
– New data include update from the fourth patient treated in the Phase 1/2 trial – Repeat topical KB105 dosing…
SAN DIEGO, July 01, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the…
SALT LAKE CITY, July 01, 2021 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and…
NEW HAVEN, Conn., July 01, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a pre-clinical,…
WATERTOWN, Mass., June 30, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein…
SAN DIEGO, June 30, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (OTC: LACQ, LACQW) today announced…
NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…
TORONTO, June 30, 2021 (GLOBE NEWSWIRE) — Avicanna Inc. (the “Company” or “Avicanna”) (TSX: AVCN) announced today that the Company’s…